Bio-Connect
WB analysis of various sample lysates using GTX33279 K-Cadherin antibody. Dilution : 1:1000 Loading : 25microg per lane
WB analysis of various sample lysates using GTX33279 K-Cadherin antibody. Dilution : 1:1000 Loading : 25microg per lane
WB analysis of various sample lysates using GTX33279 K-Cadherin antibody. Dilution : 1:1000 Loading : 25microg per lane

K-Cadherin antibody

GTX33279
GeneTex
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetCDH6
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    K-Cadherin antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500 - 1:2000. IHC-P: 1:50 - 1:200. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Conjugate
    Unconjugated
  • Gene ID1004
  • Target name
    CDH6
  • Target description
    cadherin 6
  • Target synonyms
    CAD6, KCAD, cadherin-6, cadherin 6, type 2, K-cadherin (fetal kidney)
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP55285
  • Protein Name
    Cadherin-6
  • Scientific Description
    This gene encodes a member of the cadherin superfamily. Cadherins are membrane glycoproteins that mediate homophilic cell-cell adhesion and play critical roles in cell differentiation and morphogenesis. The encoded protein is a type II cadherin and may play a role in kidney development as well as endometrium and placenta formation. Decreased expression of this gene may be associated with tumor growth and metastasis. [provided by RefSeq, May 2011]
  • Reactivity
    Human, Mouse, Rat
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Chiu IJ, Hsu YH, Chang JS, et al. Lactotransferrin Downregulation Drives the Metastatic Progression in Clear Cell Renal Cell Carcinoma. Cancers (Basel). 2020,12(4). doi: 10.3390/cancers12040847
    Read this paper